Human Biomedical Research Act
Human Biomedical Research Act, notifications, serious adverse events, suspected offences or contraventions, declaration of compliance and TIARAS.
What is the Human Biomedical Research Act (HBRA)?
The Human Biomedical Research Act (HBRA) was enacted in 2015 to provide clarity on the roles and responsibilities of individuals and body corporates involved in human biomedical research and the handling of human tissue for use in research, in order to ensure that the health, welfare, and safety of research participants remain a paramount consideration at all times.
Through the legislation, the Health Sciences Authority (HSA) strives to ensure that human biomedical research and tissue banking activities carried out in Singapore follow the law and principles of good clinical practice relating to ethics and science to protect the safety and welfare of research subjects and tissue donors.
If you have any questions or concerns about your compliance with the HBRA, please write to HSA_HBR_Enquiries@hsa.gov.sg.
Links to decision tools
About the Act
HBRA Guidance Documents
Overview of Human Biomedical Research Framework (opens in new tab)
Overview of Human Tissue Framework (updated July 2021) (opens in new tab)
Table Differentiating Research from Research-like Activities (opens in new tab)
Guidance on Prohibition against Commercial Trading of Human Tissue (opens in new tab)
